Bioventix (LON:BVXP) Shares Pass Below 200 Day Moving Average – Time to Sell?

Bioventix PLC (LON:BVXPGet Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 1,690.45 and traded as low as GBX 1,600. Bioventix shares last traded at GBX 1,700, with a volume of 2,422 shares traded.

Bioventix Stock Up 0.5%

The company’s 50-day moving average is GBX 1,678.68 and its two-hundred day moving average is GBX 1,690.04. The company has a market capitalization of £84.02 million, a P/E ratio of 11.44 and a beta of 0.55.

Bioventix (LON:BVXPGet Free Report) last released its quarterly earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 EPS for the quarter. The business had revenue of GBX 615.88 billion during the quarter. Bioventix had a net margin of 59.30% and a return on equity of 65.83%. On average, sell-side analysts predict that Bioventix PLC will post 166.3066955 EPS for the current year.

Insider Transactions at Bioventix

In other news, insider Ian James Nicholson bought 1,000 shares of Bioventix stock in a transaction that occurred on Friday, April 10th. The shares were acquired at an average price of GBX 1,848 per share, with a total value of £18,480. Also, insider Bruce Hiscock purchased 534 shares of the stock in a transaction on Wednesday, June 24th. The shares were purchased at an average price of GBX 1,799 per share, for a total transaction of £9,606.66. In the last ninety days, insiders purchased 2,665 shares of company stock valued at $4,888,665. Insiders own 6.22% of the company’s stock.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Featured Articles

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.